Design Therapeutics

(NASDAQ) DSGN

Current Price$11.08

Market Cap$685.15M

Since IPO (2021)-74%

5 Year-60%

1 Year+181%

1 Month-30%

Design Therapeutics Financials at a Glance

Market Cap

$685.15M

Revenue (TTM)

$0.00

Net Income (TTM)

-$69.71M

EPS (TTM)

-$1.19

P/E Ratio

-9.19

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$11.08

Volume

583,071.382

Open

$11.09

Price

$11.08

Volume

583,071.382

Open

$11.09

Previous Close

$10.97

Daily Range

$11.07 - $11.36

52-Week Range

$3.33 - $17.25

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$11.08

Volume

583,071.382

Open

$11.09

Previous Close

$10.97

Daily Range

$11.07 - $11.36

52-Week Range

$3.33 - $17.25

Estimated Earnings Date

Aug 10, 2026

DSGN News

Why Shares of Design Therapeutics Are Plummeting on Tuesday

James HalleyAug 15, 2023

DSGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Design Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

124

CEO

Pratik Shah, PhD, MBA

Website

www.designtx.com

Headquarters

Carlsbad, CA 92011, US

DSGN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-31%

Return on Capital

-36%

Return on Assets

-30%

Earnings Yield

-10.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$685.15M

Shares Outstanding

62.46M

Volume

583.07K

Avg. Volume

733.59K

Financials (TTM)

Gross Profit

-$622.00K

Operating Income

-$79.47M

EBITDA

-$69.17M

Operating Cash Flow

-$54.36M

Capital Expenditure

-$193.00K

Free Cash Flow

-$54.55M

Cash & ST Invst.

$219.85M

Total Debt

$1.54M

Design Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$685.15M

N/A

Market Cap/Employee

$12.23M

N/A

Employees

N/A

Net Income

-$17.64M

+0.4%

EBITDA

-$17.48M

+0.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$222.82M

-3.0%

Total Debt

$2.73M

+27.7%

Accounts Receivable

$1.82M

+29.8%

Inventory

$0.00

N/A

Long Term Debt

$2.20M

+66.5%

Short Term Debt

$536.00K

-34.7%

Return on Assets

-30.25%

N/A

Return on Invested Capital

-35.76%

N/A

Free Cash Flow

-$16.43M

+2.6%

Operating Cash Flow

-$16.43M

+2.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LBRXLB Pharmaceuticals Inc Common Stock

LBRXLB Pharmaceuticals Inc Common Stock$28.36-0.21%

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$4.57-2.97%

IMABI-Mab

IMABI-Mab$2.88-0.69%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$6.38-0.47%

RCKTRocket Pharmaceuticals, Inc.

RCKTRocket Pharmaceuticals, Inc.$2.84+3.09%

DMACDiaMedica Therapeutics Inc.

DMACDiaMedica Therapeutics Inc.$5.60-0.88%

ALTAltimmune, Inc.

ALTAltimmune, Inc.$2.61-0.19%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PAYOPayoneer Global

PAYOPayoneer Global$7.03+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.83+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.44-0.09%

ONDSOndas

ONDSOndas$9.59+0.03%

JOBYJoby Aviation

JOBYJoby Aviation$9.81+0.07%

CUPRCuprina (Cayman)

CUPRCuprina (Cayman)$7.61+0.92%

JBLUJetBlue Airways

JBLUJetBlue Airways$5.41+0.08%

Questions About DSGN

What is the current price of Design Therapeutics?

Design Therapeutics is trading at $11.09 per share.

What is the 52-week range for Design Therapeutics?

Over the past 52 weeks, Design Therapeutics has traded between $3.33 and $17.25.

How much debt does Design Therapeutics have?

As of the most recent reporting period, Design Therapeutics reported total debt of $2.73M.

How much cash does Design Therapeutics have on hand?

Design Therapeutics reported $12.77M in cash and cash equivalents in its most recent financial results.

What is Design Therapeutics’s dividend yield?

Design Therapeutics does not currently have a dividend yield.

Design Therapeutics

Design Therapeutics Financials at a Glance

DSGN News

Why Shares of Design Therapeutics Are Plummeting on Tuesday

DSGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Design Therapeutics

DSGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Design Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DSGN

What is the current price of Design Therapeutics?

What is the 52-week range for Design Therapeutics?

How much debt does Design Therapeutics have?

How much cash does Design Therapeutics have on hand?

What is Design Therapeutics’s dividend yield?

Premium Investing Services